Tau Screening Study in Patients With Early Symptomatic AD

Summary

This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.

Timeline

Start

2017-11-21

Primary completion

2018-08-31

Completion

2018-08-31

Drugs

Indications